PDB Short entry for 2KK6 HEADER TRANSFERASE 15-JUN-09 2KK6 TITLE SOLUTION STRUCTURE OF SH2 DOMAIN OF PROTO-ONCOGENE TYROSINE-PROTEIN TITLE 2 KINASE FER FROM HOMO SAPIENS, NORTHEAST STRUCTURAL GENOMICS TITLE 3 CONSORTIUM (NESG) TARGET HR3461D COMPND MOL_ID: 1; COMPND 2 MOLECULE: PROTO-ONCOGENE TYROSINE-PROTEIN KINASE FER; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: SH2 DOMAIN; COMPND 5 SYNONYM: C-FER, P94-FER, TYROSINE KINASE 3; COMPND 6 EC: 2.7.10.2; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: FER, TYK3; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_VECTOR: PET 14-15C KEYWDS METHODS DEVELOPMENT, SH2, PROTO-ONCOGENE TYROSINE-PROTEIN KINASE FER, KEYWDS 2 NESG, ATP-BINDING, CYTOPLASM, KINASE, NUCLEOTIDE-BINDING, NUCLEUS, KEYWDS 3 PHOSPHOPROTEIN, POLYMORPHISM, PROTO-ONCOGENE, SH2 DOMAIN, KEYWDS 4 TRANSFERASE, TYROSINE-PROTEIN KINASE, STRUCTURAL GENOMICS, PSI-2, KEYWDS 5 PROTEIN STRUCTURE INITIATIVE, NORTHEAST STRUCTURAL GENOMICS KEYWDS 6 CONSORTIUM EXPDTA SOLUTION NMR NUMMDL 20 AUTHOR Y.TANG,D.WANG,C.NWOSU,L.OWENS,R.XIAO,J.LIU,M.C.BARAN,G.SWAPNA, AUTHOR 2 T.B.ACTON,B.ROST,G.T.MONTELIONE,NORTHEAST STRUCTURAL GENOMICS AUTHOR 3 CONSORTIUM (NESG) REVDAT 2 26-FEB-20 2KK6 1 REMARK SEQADV REVDAT 1 11-AUG-09 2KK6 0 JRNL AUTH Y.TANG,G.T.MONTELIONE JRNL TITL SOLUTION STRUCTURE OF SH2 DOMAIN OF PROTO-ONCOGENE JRNL TITL 2 TYROSINE-PROTEIN KINASE FER FROM HOMO SAPIENS, NORTHEAST JRNL TITL 3 STRUCTURAL GENOMICS CONSORTIUM (NESG) TARGET HR3461D JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.2, CNS 1.2, CYANA 3.0, AUTOSTRUCTURE 2.1 REMARK 3 AUTHORS : BRUNGER, ADAMS, CLORE, GROS, NILGES AND READ REMARK 3 (CNS), BRUNGER, ADAMS, CLORE, GROS, NILGES AND REMARK 3 READ (CNS), GUNTERT, MUMENTHALER AND WUTHRICH REMARK 3 (CYANA), HUANG, TEJERO, POWERS AND MONTELIONE REMARK 3 (AUTOSTRUCTURE) REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2KK6 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 17-JUN-09. REMARK 100 THE DEPOSITION ID IS D_1000101221. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 298 REMARK 210 PH : 6.5 REMARK 210 IONIC STRENGTH : 0.2 REMARK 210 PRESSURE : AMBIENT REMARK 210 SAMPLE CONTENTS : 1.03 MM [U-100% 13C; U-100% 15N] REMARK 210 PROTEIN, 95% H2O/5% D2O; 1.20 MM REMARK 210 [U-10% 13C; U-100% 15N] PROTEIN, REMARK 210 95% H2O/5% D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 2D 1H-15N HSQC; 2D 1H-13C HSQC; REMARK 210 3D CBCA(CO)NH; 3D HNCACB; 3D REMARK 210 HNCO; 3D HBHA(CO)NH; 3D C(CO)NH; REMARK 210 3D 1H-15N NOESY; 3D 1H-13C NOESY; REMARK 210 3D HCCH-TOCSY REMARK 210 SPECTROMETER FIELD STRENGTH : 800 MHZ REMARK 210 SPECTROMETER MODEL : AVANCE REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : CNS 1.2, CYANA 3.0, REMARK 210 AUTOSTRUCTURE 2.1, AUTOASSIGN REMARK 210 2.1, SPARKY 2.1, NMRPIPE 2.1, REMARK 210 TOPSPIN 2.1 REMARK 210 METHOD USED : SIMULATED ANNEALING, MOLECULAR REMARK 210 DYNAMICS REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 100 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 20 REMARK 210 CONFORMERS, SELECTION CRITERIA : TARGET FUNCTION REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 LYS A 34 -49.29 -134.07 REMARK 500 1 HIS A 45 94.44 -64.21 REMARK 500 1 ILE A 97 -70.26 -57.04 REMARK 500 1 ASN A 107 88.55 30.42 REMARK 500 2 HIS A 3 18.67 59.01 REMARK 500 2 HIS A 5 99.29 -67.53 REMARK 500 2 ALA A 23 77.11 60.52 REMARK 500 2 ASN A 71 18.34 59.47 REMARK 500 2 PHE A 75 -63.74 -108.96 REMARK 500 2 GLU A 76 -71.61 -109.25 REMARK 500 2 ASN A 107 85.70 31.20 REMARK 500 3 GLN A 36 102.02 -59.05 REMARK 500 3 GLU A 76 -80.25 -114.88 REMARK 500 3 SER A 101 -60.13 -94.11 REMARK 500 3 ASN A 107 91.13 29.80 REMARK 500 4 HIS A 3 86.86 -68.46 REMARK 500 4 HIS A 7 77.86 -65.17 REMARK 500 4 GLU A 76 -44.36 -144.43 REMARK 500 4 ASN A 107 84.00 38.95 REMARK 500 4 LYS A 113 20.10 -145.48 REMARK 500 5 HIS A 7 104.43 -168.68 REMARK 500 5 SER A 9 -70.15 -56.19 REMARK 500 5 GLN A 36 108.81 -57.63 REMARK 500 5 PHE A 75 -87.90 -117.73 REMARK 500 5 ASN A 107 83.31 28.31 REMARK 500 6 HIS A 5 -81.70 -92.52 REMARK 500 6 GLU A 76 -71.21 -72.80 REMARK 500 6 ASN A 107 84.14 39.39 REMARK 500 7 PRO A 48 104.88 -58.64 REMARK 500 7 PHE A 75 -69.57 -95.44 REMARK 500 7 ASN A 107 89.18 42.69 REMARK 500 7 LYS A 114 89.75 -67.69 REMARK 500 8 HIS A 3 93.74 62.59 REMARK 500 8 HIS A 10 -168.57 -122.24 REMARK 500 8 GLU A 76 -88.89 -129.65 REMARK 500 8 SER A 101 -59.11 -121.61 REMARK 500 8 ASN A 107 86.92 41.01 REMARK 500 8 ASP A 112 107.68 -58.40 REMARK 500 9 GLU A 76 -76.00 -157.84 REMARK 500 9 ILE A 97 -66.25 -95.14 REMARK 500 9 ASN A 107 88.56 40.57 REMARK 500 9 ASP A 112 -162.78 -75.32 REMARK 500 10 HIS A 3 40.67 -81.94 REMARK 500 10 ASN A 107 79.00 37.20 REMARK 500 11 SER A 9 84.09 -65.70 REMARK 500 11 HIS A 10 142.68 -179.07 REMARK 500 11 ALA A 23 43.04 -101.97 REMARK 500 11 HIS A 45 98.60 -45.93 REMARK 500 11 PHE A 75 -76.40 -101.34 REMARK 500 11 ASN A 107 74.06 53.12 REMARK 500 REMARK 500 THIS ENTRY HAS 108 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 16353 RELATED DB: BMRB REMARK 900 RELATED ID: HR3461D RELATED DB: TARGETDB DBREF 2KK6 A 12 116 UNP P16591 FER_HUMAN 453 557 SEQADV 2KK6 MET A 1 UNP P16591 EXPRESSION TAG SEQADV 2KK6 GLY A 2 UNP P16591 EXPRESSION TAG SEQADV 2KK6 HIS A 3 UNP P16591 EXPRESSION TAG SEQADV 2KK6 HIS A 4 UNP P16591 EXPRESSION TAG SEQADV 2KK6 HIS A 5 UNP P16591 EXPRESSION TAG SEQADV 2KK6 HIS A 6 UNP P16591 EXPRESSION TAG SEQADV 2KK6 HIS A 7 UNP P16591 EXPRESSION TAG SEQADV 2KK6 HIS A 8 UNP P16591 EXPRESSION TAG SEQADV 2KK6 SER A 9 UNP P16591 EXPRESSION TAG SEQADV 2KK6 HIS A 10 UNP P16591 EXPRESSION TAG SEQADV 2KK6 MET A 11 UNP P16591 EXPRESSION TAG SEQRES 1 A 116 MET GLY HIS HIS HIS HIS HIS HIS SER HIS MET LYS PRO SEQRES 2 A 116 LEU ALA GLU GLN ASP TRP TYR HIS GLY ALA ILE PRO ARG SEQRES 3 A 116 ILE GLU ALA GLN GLU LEU LEU LYS LYS GLN GLY ASP PHE SEQRES 4 A 116 LEU VAL ARG GLU SER HIS GLY LYS PRO GLY GLU TYR VAL SEQRES 5 A 116 LEU SER VAL TYR SER ASP GLY GLN ARG ARG HIS PHE ILE SEQRES 6 A 116 ILE GLN TYR VAL ASP ASN MET TYR ARG PHE GLU GLY THR SEQRES 7 A 116 GLY PHE SER ASN ILE PRO GLN LEU ILE ASP HIS HIS TYR SEQRES 8 A 116 THR THR LYS GLN VAL ILE THR LYS LYS SER GLY VAL VAL SEQRES 9 A 116 LEU LEU ASN PRO ILE PRO LYS ASP LYS LYS TRP ILE HELIX 1 1 PRO A 25 LEU A 32 1 8 HELIX 2 2 ASN A 82 THR A 93 1 12 SHEET 1 A 6 TYR A 20 GLY A 22 0 SHEET 2 A 6 PHE A 39 GLU A 43 1 O GLU A 43 N GLY A 22 SHEET 3 A 6 TYR A 51 SER A 57 -1 O SER A 54 N LEU A 40 SHEET 4 A 6 GLN A 60 VAL A 69 -1 O ILE A 66 N TYR A 51 SHEET 5 A 6 MET A 72 ARG A 74 -1 O ARG A 74 N GLN A 67 SHEET 6 A 6 GLY A 79 PHE A 80 -1 O PHE A 80 N TYR A 73 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000